Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.
D000208:Acute Disease; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D002850:Chromatography, Gel; D004211:Disseminated Intravascular Coagulation / Q000097:blood*; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood; D007948:Leukemia, Monocytic, Acute / Q000097:blood; D007951:Leukemia, Myeloid / Q000097:blood*; D015470:Leukemia, Myeloid, Acute / Q000097:blood; D007962:Leukocytes / Q000032:analysis / Q000502:physiology*; D011817:Rabbits; D013917:Thrombin / Q000096:biosynthesis; D013925:Thromboplastin / Q000032:analysis; D014148:Tranexamic Acid / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D014361:Trypsin Inhibitors; D014148:Tranexamic Acid; D006493:Heparin; D013925:Thromboplastin; D007611:Aprotinin; D013917:Thrombin